Sintx Technologies (SINT) Cash & Equivalents Growth (3y) (2016 - 2026)
Sintx Technologies (SINT) Cash & Equivalents Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -13.31% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 34.27% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.10% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 8.16% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 40.74% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -2.57% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.72% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 38.28% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 32.23% |
| 10 | Sintx Technologies | 7.23 Mn | 7.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -46.91% |
| Dec 31, 2025 | -12.81% |
| Sep 30, 2025 | 9.36% |
| Jun 30, 2025 | -17.69% |
| Mar 31, 2025 | -15.73% |
| Dec 31, 2024 | -36.83% |
| Sep 30, 2024 | -34.57% |
| Jun 30, 2024 | -40.99% |
| Mar 31, 2024 | -37.38% |
| Dec 31, 2023 | -49.12% |
| Sep 30, 2023 | -38.74% |
| Jun 30, 2023 | -19.86% |
| Mar 31, 2023 | 15.36% |
| Dec 31, 2022 | 51.75% |
| Sep 30, 2022 | 17.77% |
| Jun 30, 2022 | 34.39% |
| Mar 31, 2022 | 37.66% |
| Dec 31, 2021 | 37.86% |
| Sep 30, 2021 | 36.25% |
| Jun 30, 2021 | 35.90% |